1. Home
  2. ICUI vs WFRD Comparison

ICUI vs WFRD Comparison

Compare ICUI & WFRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • WFRD
  • Stock Information
  • Founded
  • ICUI 1984
  • WFRD 1941
  • Country
  • ICUI United States
  • WFRD United States
  • Employees
  • ICUI N/A
  • WFRD N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • WFRD Metal Fabrications
  • Sector
  • ICUI Health Care
  • WFRD Industrials
  • Exchange
  • ICUI Nasdaq
  • WFRD Nasdaq
  • Market Cap
  • ICUI 3.4B
  • WFRD 3.0B
  • IPO Year
  • ICUI 1992
  • WFRD N/A
  • Fundamental
  • Price
  • ICUI $134.86
  • WFRD $43.60
  • Analyst Decision
  • ICUI Strong Buy
  • WFRD Strong Buy
  • Analyst Count
  • ICUI 5
  • WFRD 7
  • Target Price
  • ICUI $196.75
  • WFRD $96.43
  • AVG Volume (30 Days)
  • ICUI 272.7K
  • WFRD 1.1M
  • Earning Date
  • ICUI 05-08-2025
  • WFRD 07-22-2025
  • Dividend Yield
  • ICUI N/A
  • WFRD 2.28%
  • EPS Growth
  • ICUI N/A
  • WFRD 1.65
  • EPS
  • ICUI N/A
  • WFRD 6.29
  • Revenue
  • ICUI $2,420,093,000.00
  • WFRD $5,348,000,000.00
  • Revenue This Year
  • ICUI N/A
  • WFRD N/A
  • Revenue Next Year
  • ICUI N/A
  • WFRD $3.58
  • P/E Ratio
  • ICUI N/A
  • WFRD $6.96
  • Revenue Growth
  • ICUI 7.22
  • WFRD 0.77
  • 52 Week Low
  • ICUI $101.44
  • WFRD $36.74
  • 52 Week High
  • ICUI $196.26
  • WFRD $135.00
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 48.47
  • WFRD 41.50
  • Support Level
  • ICUI $127.91
  • WFRD $44.17
  • Resistance Level
  • ICUI $135.62
  • WFRD $46.82
  • Average True Range (ATR)
  • ICUI 4.35
  • WFRD 1.51
  • MACD
  • ICUI -0.26
  • WFRD -0.20
  • Stochastic Oscillator
  • ICUI 33.77
  • WFRD 0.79

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About WFRD Weatherford International plc

Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.

Share on Social Networks: